Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Center, Amsterdam, The Netherlands.
J Allergy Clin Immunol Pract. 2021 Jan;9(1):225-235.e10. doi: 10.1016/j.jaip.2020.08.051. Epub 2020 Sep 8.
Walnut allergy is common across the globe, but data on the involvement of individual walnut components are scarce.
To identify geographical differences in walnut component sensitization across Europe, explore cosensitization and cross-reactivity, and assess associations of clinical and serological determinants with severity of walnut allergy.
As part of the EuroPrevall outpatient surveys in 12 European cities, standardized clinical evaluation was conducted in 531 individuals reporting symptoms to walnut, with sensitization to all known walnut components assessed in 202 subjects. Multivariable Lasso regression was applied to investigate predictors for walnut allergy severity.
Birch-pollen-related walnut sensitization (Jug r 5) dominated in Northern and Central Europe and lipid transfer protein sensitization (Jug r 3) in Southern Europe. Profilin sensitization (Jug r 7) was prominent throughout Europe. Sensitization to storage proteins (Jug r 1, 2, 4, and 6) was detected in up to 10% of subjects. The walnut components that showed strong correlations with pollen and other foods differed between centers. The combination of determinants best predicting walnut allergy severity were symptoms upon skin contact with walnut, atopic dermatitis (ever), family history of atopic disease, mugwort pollen allergy, sensitization to cat or dog, positive skin prick test result to walnut, and IgE to Jug r 1, 5, 7, or carbohydrate determinants (area under the curve = 0.81; 95% CI, 0.73-0.89).
Walnut-allergic subjects across Europe show clear geographical differences in walnut component sensitization and cosensitization patterns. A predictive model combining results from component-based serology testing with results from extract-based testing and information on clinical background allows for good discrimination between mild to moderate and severe walnut allergy.
全球范围内普遍存在核桃过敏,但有关个别核桃成分致敏情况的数据却很少。
确定欧洲各地核桃成分致敏情况的地域差异,探讨共同致敏和交叉反应,并评估临床和血清学指标与核桃过敏严重程度的相关性。
作为 12 个欧洲城市的 EuroPrevall 门诊调查的一部分,对 531 名报告核桃过敏症状的个体进行了标准化临床评估,对 202 名个体评估了所有已知核桃成分的致敏情况。采用多变量套索回归分析探讨核桃过敏严重程度的预测因素。
北欧和中欧以桦树花粉相关的核桃致敏(Jug r 5)为主,南欧以脂质转移蛋白致敏(Jug r 3)为主。整个欧洲都以原肌球蛋白致敏(Jug r 7)为主。多达 10%的个体对贮藏蛋白(Jug r 1、2、4 和 6)致敏。显示与花粉和其他食物具有强相关性的核桃成分在各中心之间存在差异。最佳预测核桃过敏严重程度的组合决定因素包括皮肤接触核桃后的症状、特应性皮炎(既往)、特应性疾病家族史、艾蒿花粉过敏、对猫或狗的致敏、对核桃的皮肤点刺试验阳性结果以及 IgE 对 Jug r 1、5、7 或碳水化合物决定因素的阳性(曲线下面积=0.81;95%置信区间,0.73-0.89)。
欧洲各地的核桃过敏患者在核桃成分致敏和共同致敏模式方面存在明显的地域差异。一个结合基于成分的血清学检测结果、基于提取物的检测结果以及临床背景信息的预测模型,可以很好地区分轻度至中度和重度核桃过敏。